Workflow
DQHK(000985)
icon
Search documents
大庆华科(000985) - 2021 Q4 - 年度财报
2022-04-29 16:00
Financial Performance - The company's operating revenue for 2021 was ¥2,073,428,194.93, an increase of 17.60% compared to ¥1,763,044,476.17 in 2020[17]. - The net profit attributable to shareholders for 2021 was ¥12,842,754.34, reflecting a growth of 5.88% from ¥12,129,725.55 in 2020[17]. - The net profit attributable to shareholders after deducting non-recurring gains and losses surged by 211.20% to ¥9,547,556.30 from ¥3,068,025.86 in 2020[17]. - The company's total assets at the end of 2021 amounted to ¥705,436,187.12, a 1.55% increase from ¥694,655,529.43 at the end of 2020[17]. - The weighted average return on net assets for 2021 was 2.19%, up from 2.08% in 2020[17]. - The company reported a net cash flow from operating activities of ¥63,163,053.33, a slight decrease of 1.21% compared to ¥63,938,916.62 in 2020[17]. - The total operating revenue for 2021 was ¥2,073,428,194.93, representing a 17.60% increase from ¥1,763,044,476.17 in 2020[56]. - The gross profit margin for the chemical industry was 5.86%, with operating costs increasing by 19.54% year-over-year to ¥1,951,879,305.00[56]. - The total cost of sales for the year was 1,955,000,000.00 CNY, with a gross margin of approximately 5.55%[67]. - The company achieved operating revenue of 2.073 billion yuan and a net profit of 12.84 million yuan in 2021[53]. Shareholder Information - The company plans to distribute a cash dividend of 0.46 RMB per 10 shares to all shareholders, based on a total of 129,639,500 shares[4]. - The total distributable profit for shareholders was CNY 102.4454 million, after accounting for a net profit of CNY 12.8428 million and retained earnings from the previous year[106]. - The cash dividend accounted for 100% of the total profit distribution, adhering to the policy that at least 80% of profits should be distributed as cash dividends during the mature phase of the company[106]. - The company did not make any adjustments or changes to its cash dividend policy during the reporting period[106]. Business Operations - The company has not changed its business scope during the reporting period, which includes the production and sales of chemical products and health food[15]. - The company has undergone several changes in its major business operations since its establishment, including the addition of import and export business in 2001[15]. - The company produces a range of products including C9 and C5 resins, refined acetonitrile, and polypropylene, widely used in various industrial applications[42]. - The company has a production capacity of 14,000 tons/year for dark C9 resin and 6,000 tons/year for hot polymerized C9 resin, with stable product quality and target customers[32]. - The company’s main product categories included polypropylene and its modified products, which generated ¥760,916,295.09, accounting for 36.70% of total revenue, with a 20.40% year-over-year increase[56]. Market Outlook - The company anticipates a stable growth in the petrochemical industry in 2022, driven by energy transformation and demand growth in the new energy sector[25]. - The demand for C5 petroleum resin, a key product of the company, is expected to maintain a growth trend due to its wide applications in various industries[29]. - The company is expanding its market presence, targeting a 25% increase in market share in the next fiscal year[79]. - New product launches are expected to contribute an additional 300 million RMB in revenue in 2022[82]. Research and Development - The company has a stable core management team and a professional R&D team of 68 members, including 34 senior engineers[51]. - Research and development expenses for 2021 were CNY 7,584,466.29, slightly down from CNY 8,550,467.12 in 2020, a decrease of 11.3%[172]. - The company is in the trial production phase for several new products, including C5/C9 copolymer resin, aimed at enhancing product variety and profitability[64]. - Research and development investments increased by 30%, totaling 150 million RMB in 2021[80]. Risk Management - The company faces risks from macroeconomic fluctuations, energy policies, and international oil price volatility, which could impact operational performance[34][39]. - To mitigate risks, the company is focusing on high-value product development and optimizing production processes to enhance competitiveness[41]. - The company’s risk management capabilities were enhanced through the establishment of a comprehensive internal control system, effectively mitigating operational risks[55]. Environmental and Social Responsibility - The company maintained a zero incident rate for environmental pollution throughout the year, achieving 100% compliance in various safety and health metrics[55]. - The company reported a year-on-year decrease in CO2 emissions by 657.89 tons due to enhanced energy-saving measures and optimized production processes[117]. - The company has actively engaged in social responsibility initiatives, balancing economic and social benefits[119]. - The company invested 3.69 million yuan in safety production measures, including monitoring and health checks for employees[121]. Governance and Compliance - The company maintains a complete and independent governance structure, ensuring compliance with relevant laws and regulations[76]. - The financial statements are audited by Dahua Certified Public Accountants[16]. - The audit opinion for the financial statements is a standard unqualified opinion, indicating fair representation of the company's financial status as of December 31, 2021[150]. - The company has established a comprehensive salary management system, aligning compensation with industry standards and company performance[100]. Employee Information - The total number of employees at the end of the reporting period is 573, with 386 in production, 115 in technical roles, and 18 in sales[99]. - The total salary expense for employees is CNY 9,928.33 million, accounting for 4.82% of total costs, with R&D personnel salaries totaling CNY 740.86 million, representing 7.46% of total salary expenses[102]. - A total of 94 internal training sessions were completed, training 4,126 employees, while 51 external training sessions trained 190 employees, enhancing skills and responsibility[102].
大庆华科(000985) - 2022 Q1 - 季度财报
2022-04-29 16:00
Financial Performance - The company's operating revenue for Q1 2022 was ¥616,709,642.53, representing a 36.22% increase compared to ¥452,727,892.35 in the same period last year[3] - Net profit attributable to shareholders was ¥12,964,510.88, a significant increase of 659.11% from a loss of ¥2,318,782.60 in the previous year[3] - The net profit after deducting non-recurring gains and losses was ¥12,329,026.83, up 506.88% from a loss of ¥3,030,159.26 in the same period last year[3] - The basic earnings per share increased to ¥0.10 from a loss of ¥0.02, marking a 600.00% improvement[3] - Net profit for the quarter was ¥12,964,510.88, a turnaround from a net loss of ¥2,318,782.60 in the same period last year[15] Assets and Liabilities - The total assets at the end of the reporting period were ¥732,788,207.52, a 3.88% increase from ¥705,436,187.12 at the end of the previous year[3] - The equity attributable to shareholders increased by 2.62% to ¥607,812,084.96 from ¥592,292,056.90 at the end of the previous year[3] - Current assets totaled ¥367,545,795.43, up from ¥330,182,684.08, indicating an increase of 11.3%[12] - Inventory levels rose significantly to ¥109,247,418.59 from ¥66,482,080.58, representing a 64.3% increase[12] - The total liabilities increased to ¥124,976,122.56 from ¥113,144,130.22, reflecting a growth of 10.5%[13] Cash Flow - The net cash flow from operating activities was negative at -¥5,052,681.00, a decline of 123.19% compared to ¥21,787,016.61 in the same period last year[3] - Cash inflow from sales of goods and services reached 701,519,167.69, compared to 522,070,848.87 in the prior period, reflecting a growth of approximately 34.4%[18] - Total cash outflow from operating activities was 709,353,122.47, up from 504,068,953.58, representing an increase of about 40.7%[19] - The cash flow from investment activities was -2,905,940.56, an improvement from -3,037,034.82 in the previous period[19] - The net increase in cash and cash equivalents was -7,958,621.56, contrasting with an increase of 18,749,981.79 in the prior period[19] Operating Costs - The company reported a significant increase in operating costs, which rose by 34.15% to ¥573,268,363.05 due to higher raw material prices compared to the previous year[6] - Operating costs amounted to ¥601,545,404.03, up from ¥455,649,510.26, reflecting a rise of 32.0% year-over-year[14] - Cash paid for purchasing goods and services was 672,458,075.55, an increase from 473,587,076.40, showing a rise of approximately 42.0%[18] Research and Development - Research and development expenses increased to ¥3,677,702.08 from ¥2,330,889.93, showing a growth of 57.8% year-over-year[15] Shareholder Information - The top shareholder, China Petroleum Daqing Petrochemical Co., Ltd., holds 55.03% of the shares, totaling 71,339,700 shares[6] Government Subsidies - The company received government subsidies amounting to ¥723,137.15 during the reporting period[5] Taxation - The company paid 6,438,476.12 in taxes, significantly higher than 1,165,562.51 in the previous period, marking an increase of about 450.0%[19]
大庆华科(000985) - 2022 Q1 - 季度财报
2022-04-29 16:00
大庆华科股份有限公司 2022 年第一季度报告全文 证券代码:000985 证券简称:大庆华科 公告编号:2022017 大庆华科股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、误导 性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整,不存在虚假记载、误导性陈述或重大遗漏,并承担个别和连带的法 律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明:保证季度报告中财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司不存在其他符合非经常性损益定义的损益项目的具体情况。 公司不存在将《公开发行证券的公司信息披露解释性公告第 1 号——非经 常性损益》中列举的非经常性损益项目界定为经常性损益的项目的情形。 二、股东信息 (一)普通股股东总数和表决权恢复的优先股股东数量及前十名股东持股情 况表 公司无需追溯调整或重述以前年度会计数据 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | ...
大庆华科(000985) - 2021 Q3 - 季度财报
2021-10-22 16:00
Financial Performance - The company's revenue for Q3 2021 was ¥539,811,195.48, representing a year-on-year increase of 12.31%[3] - The net profit attributable to shareholders for Q3 2021 was ¥8,559,582.73, a decrease of 50.05% compared to the same period last year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥6,932,638.49, down 57.97% year-on-year[3] - The basic earnings per share for Q3 2021 was ¥0.07, a decline of 50.08% compared to the same period last year[3] - Operating profit for the current period was ¥16,380,921.66, compared to ¥13,800,031.44 in the previous period, indicating a growth of 18.7%[9] - Net profit decreased to ¥13,047,610.87 from ¥13,767,428.14, representing a decline of 5.2% year-over-year[19] - The company reported a total comprehensive income of ¥13,047,610.87, down from ¥13,767,428.14, indicating a decline of 5.2%[19] - The basic and diluted earnings per share were both ¥0.101, down from ¥0.106 in the previous period[19] Assets and Liabilities - The total assets at the end of Q3 2021 amounted to ¥769,089,948.35, reflecting a 10.72% increase from the end of the previous year[4] - As of September 30, 2021, the company's total assets amounted to CNY 769,089,948.35, an increase from CNY 694,655,529.43 at the end of 2020[15] - The company's total liabilities as of September 30, 2021, were CNY 176,989,702.06, compared to CNY 116,453,469.16 at the end of 2020, indicating a significant increase in liabilities[16] - The company's total equity attributable to shareholders at the end of Q3 2021 was ¥592,100,246.29, a 2.40% increase from the previous year[4] - The company's total equity as of September 30, 2021, was CNY 592,100,246.29, compared to CNY 578,202,060.27 at the end of 2020, showing a growth in shareholder equity[16] - The company reported a significant increase in contract liabilities, which rose to CNY 41,405,195.66 from CNY 15,531,511.07 year-over-year[16] - The company’s non-current liabilities decreased slightly to CNY 50,776,653.40 from CNY 54,097,674.10, indicating a reduction in long-term obligations[16] Cash Flow and Liquidity - The net cash flow from operating activities for the year-to-date period was ¥133,418,346.74, an increase of 17.08%[3] - Cash flow from operating activities generated a net amount of ¥133,418,346.74, an increase from ¥113,954,678.24 in the previous period[22] - The company's cash and cash equivalents increased to CNY 340,206,551.85 as of September 30, 2021, up from CNY 219,880,931.48 at the end of 2020, reflecting improved liquidity[14] - Cash and cash equivalents at the end of the period totaled ¥340,206,551.85, up from ¥302,180,961.42, marking an increase of 12.6%[23] Expenses - Total operating costs amounted to ¥1,523,485,605.05, up from ¥1,332,553,108.56, reflecting a year-over-year increase of 14.3%[9] - Research and development expenses were ¥5,983,615.14, slightly down from ¥6,125,998.01, reflecting a decrease of 2.3%[9] - Sales expenses decreased significantly to ¥5,028,156.92 from ¥10,392,450.16, a reduction of 51.6%[9] Corporate Actions - The company completed the internal decision-making process for the transfer of state-owned shares, with 20,339,700 shares (15.69% of total shares) being transferred from Lin Yuan Refinery to Daqing Petrochemical on August 16, 2021[10] - The company announced the resignation of Chairman Ma Tiegang on July 9, 2021, which may impact future strategic direction[9]
大庆华科(000985) - 2021 Q2 - 季度财报
2021-08-27 16:00
Financial Performance - The company's operating revenue for the first half of 2021 was approximately ¥998.88 million, representing a 14.69% increase compared to ¥870.97 million in the same period last year[15]. - The net profit attributable to shareholders was approximately ¥4.49 million, a significant turnaround from a loss of ¥3.37 million in the previous year, marking a 233.25% increase[15]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥3.61 million, compared to a loss of ¥5.97 million last year, reflecting a 160.46% improvement[15]. - The company reported a basic earnings per share of ¥0.035, compared to a loss of ¥0.026 per share in the same period last year, representing a 234.62% increase[15]. - Total revenue for the period reached ¥998,882,107.63, representing a year-on-year increase of 14.69% compared to ¥870,967,395.05 in the same period last year[40]. - The company reported a significant increase in overseas sales, which rose by 20.35% to ¥32,240,017.59, representing 3.23% of total revenue[42]. - The company’s total operating expenses increased to CNY 1,105,224,985.94, compared to CNY 928,989,485.23 in the first half of 2020, reflecting a rise of 19%[94]. Assets and Liabilities - The company's total assets at the end of the reporting period were approximately ¥721.67 million, up 3.89% from ¥694.66 million at the end of the previous year[16]. - The net assets attributable to shareholders increased to approximately ¥581.63 million, a 0.59% rise from ¥578.20 million at the end of the previous year[16]. - Total liabilities rose to ¥140,038,572.58 from ¥116,453,469.16, reflecting an increase of 20.2%[89]. - The inventory level increased to ¥84,781,579.14, which is 11.75% of total assets, up from 8.80% last year[44]. Cash Flow - The cash and cash equivalents increased significantly to approximately ¥24.72 million, a 233.16% year-on-year rise, primarily due to reduced cash expenditures in investment and financing activities[38]. - Operating cash inflow for the first half of 2021 was CNY 1,140,599,940.64, an increase of 17.4% compared to CNY 971,543,540.10 in the first half of 2020[93]. - Net cash flow from operating activities decreased to CNY 35,374,954.70, down 16.7% from CNY 42,554,054.87 in the same period last year[94]. - Cash outflow from investing activities was CNY 4,735,371.60, significantly lower than CNY 14,444,857.09 in the first half of 2020, resulting in a net cash flow from investing activities of -CNY 4,692,846.60[94]. - Cash outflow from financing activities decreased to CNY 5,963,417.00 from CNY 20,742,320.00 in the previous year, indicating a reduction of 71.2%[94]. Market and Sales - The company exported products to over 20 countries and regions, with export volume and export value increasing by 46.58% and 16.40% respectively compared to the same period last year[24]. - Domestic sales contributed ¥966,642,090.04, which is 96.77% of total revenue, showing a slight decrease of 0.05% year-on-year[40]. - Polypropylene sales amounted to ¥377,340,824.79, accounting for 37.78% of total revenue, with a year-on-year growth of 3.06%[40]. Research and Development - Research and development investment rose by 5.47% year-on-year to approximately ¥4.32 million, reflecting the company's commitment to innovation[37]. - The company has received national invention patent authorization for several new processing technologies, enhancing its competitive edge in the market[35]. - The company is focusing on high-value product development and sustainable growth, leveraging regional advantages and collaboration with upstream and downstream industries[35]. Environmental and Regulatory Compliance - The company has implemented measures to address environmental protection risks, including compliance with new regulations and increased investment in energy-saving initiatives[47]. - The company has obtained pollution discharge permits for its resin, chemical, and polypropylene divisions in accordance with national regulations[56]. - The company has developed emergency response plans for environmental incidents and has conducted environmental monitoring as per regulatory requirements[56]. - The company was listed as a key regulatory enterprise for soil pollution in Daqing City and has initiated soil environmental monitoring plans[57]. Shareholder and Corporate Governance - The company emphasizes maintaining shareholder interests and has established a comprehensive internal control system[60]. - The company held its first extraordinary general meeting of shareholders in 2021 with a participation rate of 63.51% on February 25, 2021[51]. - The company plans not to distribute cash dividends or issue bonus shares for the semi-annual period[51]. - There were no stock incentive plans or employee stock ownership plans implemented during the reporting period[52]. Related Party Transactions - The company reported a total of 90,807.72 million CNY in related party transactions, accounting for 98.69% of similar transactions[67]. - The company engaged in raw material procurement with China National Petroleum Corporation, amounting to 89,788.59 million CNY[67]. - The company accepted labor services from Daqing Petrochemical Branch, totaling 232.41 million CNY, which represents 77.16% of the approved limit[67]. Accounting Policies and Estimates - The company follows specific accounting policies and estimates based on its operational characteristics, particularly in inventory valuation and fixed asset depreciation[112]. - The company assesses significant accounting estimates and key assumptions continuously, particularly regarding inventory impairment and long-term asset impairment[113]. - The company’s accounting policies comply with the requirements of the enterprise accounting standards, reflecting its financial position and operating results accurately[114].
大庆华科(000985) - 2020 Q4 - 年度财报
2021-04-23 16:00
Financial Performance - The company's operating revenue for 2020 was CNY 1,763,044,476.17, a decrease of 18.22% compared to CNY 2,155,889,874.89 in 2019[10] - The net profit attributable to shareholders for 2020 was CNY 12,129,725.55, down 72.88% from CNY 44,727,554.06 in 2019[10] - The net profit after deducting non-recurring gains and losses was CNY 3,068,025.86, a decline of 92.28% from CNY 39,734,567.11 in the previous year[11] - The basic earnings per share for 2020 was CNY 0.09, a decrease of 74.29% compared to CNY 0.35 in 2019[11] - The total assets at the end of 2020 were CNY 694,655,529.43, a decrease of 6.26% from CNY 741,035,161.69 at the end of 2019[11] - The net assets attributable to shareholders at the end of 2020 were CNY 578,202,060.27, showing a slight increase of 0.01% from CNY 578,122,678.53 at the end of 2019[11] - The net cash flow from operating activities was CNY 63,938,916.62, down 46.43% from CNY 119,361,712.66 in 2019[11] - The weighted average return on net assets for 2020 was 2.08%, a decrease of 6.02% from 8.10% in 2019[11] Revenue and Sales - The company achieved total operating revenue of CNY 1.763 billion in 2020, with a net profit attributable to shareholders of CNY 12.13 million[20] - The chemical segment accounted for 100% of total revenue, with a gross margin of 7.38%, down from the previous year[24] - Domestic revenue decreased by 20.19% to ¥1,696,139,813.08, while international revenue increased by 118.39% to ¥66,904,663.09[25] - Sales volume in the chemical industry was 531,280.19 tons, a decline of 2.22% from 543,326.73 tons in 2019[25] - The company reported a significant increase in the sales of isoprene resin, with revenue rising by 43.02% to ¥181,137,641.21[25] Costs and Expenses - The overall cost of sales for the chemical segment was ¥1,632,852,489.27, a decrease from ¥1,982,143,300.16 in the previous year[28] - In 2020, the total operating costs amounted to 1,632,000,000.00 CNY, with a significant decrease in the cost of hydrogenated pentene by 1.14% compared to 2019[29] - Research and development expenses decreased by 11.27% to 8,550,467.12 CNY, representing 0.48% of total operating revenue[32] Investments and Dividends - The company plans to distribute a cash dividend of CNY 0.46 per 10 shares, based on a total of 129,639,500 shares[7] - The company reported a net profit of 12.13 million yuan for 2020, with a cash dividend proposal of 0.46 yuan per share, totaling approximately 596.34 million yuan in cash dividends[44] - Total investment during the reporting period was 6.93 million yuan, a significant decrease of 85.76% compared to the previous year's investment of 48.68 million yuan[37] Market and Operational Developments - The company successfully expanded its foreign market presence, achieving over USD 10 million in foreign exchange income, marking a historical high[21] - The company implemented 46 measures for quality improvement and efficiency enhancement, resulting in an increase of CNY 15.39 million in effectiveness[21] - The company maintained a stable production operation with zero environmental pollution incidents throughout the year[21] Research and Development - The company has a strong focus on R&D, with 11.8% of its workforce dedicated to research and development activities[18] - The company has received multiple national and provincial awards for its new products, enhancing its market competitiveness[17] Financial Stability and Management - The company’s asset-liability ratio and net liability ratio are at a favorable level within the industry, ensuring financial stability[18] - The company’s core management team and key technical personnel remain stable, contributing to its competitive advantage[17] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 11,221, an increase from 11,191 at the end of the previous month[66] - China National Petroleum Daqing Petrochemical Co., Ltd. holds a 39.34% stake in the company, amounting to 51 million shares, with no changes during the reporting period[67] Compliance and Governance - The company has established a comprehensive internal control system to protect the interests of shareholders, especially minority shareholders[57] - The company has maintained its accounting firm, Dahua Certified Public Accountants, for two consecutive years, with an audit fee of 420,000 yuan[48] - The independent directors did not raise any objections regarding the company's matters during the reporting period[97] Environmental and Safety Compliance - The company has achieved ISO9001:2015 quality system certification and Q/SY1002.1-2013 health safety environment management system certification[60] - The company has not experienced any major safety production accidents or environmental pollution incidents during the reporting period[61] - The company conducted environmental monitoring of wastewater and emissions on a monthly, quarterly, and annual basis, ensuring compliance with the technical guidelines for self-monitoring in the petrochemical industry[63]
大庆华科(000985) - 2021 Q1 - 季度财报
2021-04-23 16:00
Financial Performance - The company's operating revenue for Q1 2021 was ¥452,727,892.35, a slight increase of 0.27% compared to ¥451,505,707.61 in the same period last year[9] - The net profit attributable to shareholders was a loss of ¥2,318,782.60, significantly improved by 90.57% from a loss of ¥24,580,451.49 in the previous year[9] - The net cash flow from operating activities increased by 151.55% to ¥21,787,016.61, compared to a negative cash flow of ¥42,263,402.37 in the same period last year[9] - The basic earnings per share for Q1 2021 was -¥0.02, an improvement of 89.47% from -¥0.19 in the same period last year[9] - The weighted average return on equity improved to -0.32% from -4.42% year-on-year, indicating a recovery in financial performance[9] - The total comprehensive income attributable to the parent company's owners for Q1 2021 was -2,318,782.60 CNY, compared to -24,580,451.49 CNY in the same period last year[26] - Basic and diluted earnings per share for Q1 2021 were both -0.02 CNY, compared to -0.19 CNY in Q1 2020[26] Assets and Liabilities - The total assets at the end of the reporting period were ¥714,641,131.93, reflecting a 2.88% increase from ¥694,655,529.43 at the end of the previous year[9] - Total assets amounted to CNY 714,641,131.93, up from CNY 694,655,529.43, showing a growth of 2.14%[24] - Total liabilities increased to CNY 136,254,542.66 from CNY 116,453,469.16, an increase of 17.15%[23] - The company’s total equity increased slightly to CNY 578,386,589.27 from CNY 578,202,060.27, reflecting a growth of 0.032%[24] Cash Flow - Cash and cash equivalents increased to CNY 238,630,913.27 from CNY 219,880,931.48, reflecting a growth of 8.42%[21] - The net increase in cash and cash equivalents for Q1 2021 was 18,749,981.79 CNY, compared to a decrease of -44,813,067.14 CNY in Q1 2020[27] - The ending balance of cash and cash equivalents as of the end of Q1 2021 was 238,630,913.27 CNY, up from 175,853,089.77 CNY at the end of Q1 2020[27] - Cash inflow from operating activities totaled 525,855,970.19 CNY, while cash outflow was 504,068,953.58 CNY in Q1 2021[27] - The company did not report any cash inflows from investment activities in Q1 2021, while cash outflows were 3,037,034.82 CNY[27] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,191, with the top three shareholders holding a combined 63.50% of the shares[12] Operational Changes - The company has not engaged in any securities or derivative investments during the reporting period[16] - The company reported no significant non-recurring gains or losses during the reporting period[11] - The company is implementing new leasing standards starting in 2021, but it does not apply to the current financial statements[29] - The company has not yet audited the Q1 2021 report[29] Future Projections - The company expects a turnaround in profitability for the first half of 2021, projecting a net profit attributable to shareholders between ¥5,200,000 and ¥6,700,000, representing a growth of 254.39% to 298.93% compared to the same period last year[16] Expenses - Total operating costs decreased to CNY 455,649,510.26 from CNY 470,708,458.55, a reduction of approximately 3.20%[24] - The company reported a decrease in selling expenses to CNY 1,450,676.73 from CNY 2,433,837.79, a reduction of 40.38%[24] - Research and development expenses rose to CNY 2,330,889.93 from CNY 2,151,540.95, an increase of 8.34%[24] Presentation - The report was presented by Chairman Ma Tiegang on April 22, 2021[30]
大庆华科:关于参加投资者网上集体接待日活动的公告
2020-11-10 08:53
证券代码:000985 证券简称:大庆华科 公告编号:2020031 大庆华科股份有限公司关于参加 投资者网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流,大庆华科股份有限公司(以 下简称"公司")将参加由黑龙江省上市公司协会、深圳市全景网络 有限公司共同举办的"黑龙江省上市公司 2020 年度投资者网上集体 接待日"活动,现将有关事项公告如下: 本次集体接待日活动将通过深圳市全景网络有限公司提供的互 联网平台举行,投资者可以登陆 " 全 景 · 路 演 天 下 " 网 站 (http://rs.p5w.net)参与公司本次投资者集体接待日活动,时间 为 2020 年 11 月 12 日 14:00 至 16:30。 届时公司董事、总经理韩月辉先生,副总经理、董事会秘书孟凡 礼先生将通过网络在线问答互动的形式,与投资者就公司治理、发展 经营情况、融资情况和可持续发展等投资者关注的问题进行交流。期 间,公司高管将全程在线,实时回答投资者的提问。 欢迎广大投资者积极参与。 特此公告。 大庆华科股份有限公司 2 ...
大庆华科(000985) - 2020 Q3 - 季度财报
2020-10-28 16:00
Financial Performance - Operating revenue for the reporting period was ¥480,623,290.20, a decrease of 20.08% year-on-year[7] - Net profit attributable to shareholders was ¥17,135,448.07, down 37.55% compared to the same period last year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥16,493,625.72, a decline of 38.59% year-on-year[7] - Basic earnings per share for the reporting period was ¥0.132, a decrease of 37.74% compared to the same period last year[7] - Operating profit fell by 75.45% to ¥13,802,426.13 from ¥56,211,952.23, primarily impacted by the pandemic and market conditions[13] - Net profit decreased by 74.59% to ¥13,767,428.14 from ¥54,182,144.89, reflecting similar challenges as operating profit[13] - The company expects a net profit of ¥950,000 for the year, a decrease of 73.17% compared to ¥4,472,760 from the previous year[15] - Basic earnings per share are projected to be ¥0.073, down 73.43% from ¥0.35 in the previous year[15] Assets and Liabilities - Total assets at the end of the reporting period reached ¥759,919,834.91, an increase of 2.55% compared to the end of the previous year[7] - Total liabilities as of Q3 2020 amounted to ¥181,453,204.55, an increase of 11.00% from ¥162,912,483.16 in the previous year[20] - Total equity for Q3 2020 was ¥578,466,630.36, slightly up from ¥578,122,678.53 in Q3 2019[20] - Cash and cash equivalents increased by 36.94% to ¥302,180,961.42 from ¥220,666,156.91 due to higher net cash flow during the period[13] Cash Flow - The net cash flow from operating activities was ¥71,400,623.37, a decrease of 7.81% compared to the previous year[7] - The cash flow from operating activities for Q3 2020 was ¥113,954,678.24, down from ¥140,393,778.82 in Q3 2019, a decline of about 18.8%[31] - The company received cash inflows from operating activities totaling ¥1,525,428,842.90 in Q3 2020, compared to ¥1,942,198,107.42 in Q3 2019, a decrease of approximately 21.5%[31] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,287[10] - The largest shareholder, China Petroleum Daqing Oilfield Chemical Co., Ltd., holds 51,000,000 shares, accounting for 39.34% of the total shares[10] Other Financial Metrics - The weighted average return on net assets was 2.96%, down 1.74% year-on-year[7] - Other income increased by 42.30% to ¥2,146,580.08 from ¥1,508,480.00, mainly due to government subsidies[13] - The company received tax refunds of ¥4,010,100.51, a 91.21% increase from ¥2,097,222.35, attributed to higher export tax rebates[13] - Long-term prepaid expenses decreased by 39.98% to ¥1,746,861.05 from ¥2,910,596.24 due to amortization during the period[13] - The company reported a significant increase of 727.17% in taxes payable, rising to ¥2,392,259.24 from ¥289,209.41, due to higher corporate income tax provisions[13] Quarterly Performance - Total operating revenue for Q3 2020 was ¥480,623,290.20, a decrease of 20.05% from ¥601,385,645.22 in Q3 2019[22] - Total operating costs for Q3 2020 were ¥461,510,830.28, down 19.48% from ¥573,211,334.64 in the same period last year[22] - Net profit for Q3 2020 was ¥17,135,448.07, representing a decline of 37.66% compared to ¥27,440,334.03 in Q3 2019[23] - Earnings per share for Q3 2020 was ¥0.132, down from ¥0.212 in Q3 2019, reflecting a decrease of 37.74%[24] - Research and development expenses for Q3 2020 were ¥2,027,686.96, a decrease of 25.41% from ¥2,716,767.43 in Q3 2019[23] - The company reported a financial expense of -¥1,518,125.62 in Q3 2020, compared to -¥1,326,471.72 in the same period last year[23] - Deferred income for Q3 2020 was ¥21,853,190.09, an increase of 43.59% from ¥15,206,815.99 in Q3 2019[20] - The total profit for Q3 2020 was ¥15,472,384.11, down from ¥56,389,314.27 in Q3 2019, reflecting a decrease of about 72.6%[27]
大庆华科(000985) - 2020 Q2 - 季度财报
2020-08-28 16:00
Financial Performance - The company's operating revenue for the first half of 2020 was ¥870,967,395.05, a decrease of 19.64% compared to ¥1,083,799,375.49 in the same period last year[10]. - The net profit attributable to shareholders was a loss of ¥3,368,019.93, representing a decline of 112.59% from a profit of ¥26,741,810.86 in the previous year[10]. - The net cash flow from operating activities decreased by 32.39%, amounting to ¥42,554,054.87 compared to ¥62,943,998.00 in the prior year[10]. - The company reported a revenue of CNY 870.97 million, a decrease of 19.64% compared to the previous year's CNY 1,083.80 million, primarily due to the impact of the COVID-19 pandemic and a decline in international oil prices[19]. - Operating costs decreased by 18.04% to CNY 807.23 million from CNY 984.95 million, attributed to lower sales volumes and prices of major chemical products[19]. - The net profit for the period was a loss of CNY 336.80 million, with no income tax expenses recorded due to operational losses[19]. - The estimated net profit for the period from January to September 2020 is projected to be ¥12.5 million, representing a decline of 71.39% compared to ¥54.18 million in the same period last year[27]. - Basic earnings per share are expected to be ¥0.096, down 71.29% from ¥0.418 in the same period last year[27]. - The company anticipates a significant decline in performance due to losses in the first half of the year, despite a gradual recovery in the petrochemical industry as the impact of COVID-19 diminishes[27]. Assets and Liabilities - The total assets at the end of the reporting period were ¥710,003,958.42, down 4.19% from ¥741,035,161.69 at the end of the previous year[11]. - The total liabilities decreased to CNY 151,347,958.86 from CNY 162,912,483.16, indicating a reduction of about 7.5%[62]. - The company reported a significant reduction in accounts payable, which decreased from CNY 50,348,005.54 to CNY 35,843,284.84, a decline of approximately 28.8%[62]. - The total equity attributable to the parent company at the end of the first half of 2020 was CNY 578,122,678.53, a decrease of CNY 19,466,678.97 compared to the beginning of the year[71]. - The total equity at the end of the reporting period is CNY 578,122,678.53[77]. Investments and R&D - The company plans to continue focusing on the production and sales of petrochemical products, with a product range that includes 12 varieties and 54 grades[13]. - Research and development expenses were CNY 4.10 million, down 19.63% from CNY 5.10 million, mainly due to reduced labor costs in R&D[19]. - The company has made significant investments in research and development across various resin projects, highlighting a focus on innovation and market expansion[193]. Shareholder Information - The company does not plan to distribute cash dividends or issue bonus shares for the reporting period[5]. - The company will not distribute cash dividends or issue bonus shares for the half-year period[34]. - As of the end of the reporting period, the total number of ordinary shareholders was 9,713[49]. - The largest shareholder, China Petroleum Daqing Oilfield Chemical Co., Ltd., holds 51,000,000 shares, representing 39.34% of the total shares[49]. Environmental and Safety Management - The company has established emergency response plans for environmental incidents, which have passed expert reviews[41]. - The company’s environmental monitoring plan includes monthly, quarterly, and annual assessments of wastewater and emissions, as well as noise monitoring[41]. - The company was listed as a key regulatory enterprise for soil pollution in both the provincial and municipal environmental protection directories[41]. Market and Competitive Position - The company plans to enhance its competitiveness by accelerating the development of high value-added products and optimizing resource allocation[30]. - The company maintains a stable core management team and has implemented strict quality and safety management systems[15]. - The company holds several national invention patents for its production technologies, enhancing its competitive edge in the market[16]. Related Party Transactions - The company reported a total of 76,411.99 thousand yuan in related party transactions, with 98.95% of this amount related to raw material procurement from China National Petroleum Corporation[37]. - The company’s related party transactions accounted for 0.52% of total sales, indicating a low level of dependency on related parties for revenue[37]. Accounting Policies and Financial Instruments - The company’s financial statements are prepared based on the assumption of continued operations[83]. - The company follows accounting standards that ensure financial statements accurately reflect its financial position, operating results, and cash flows[84]. - Financial assets are classified into three categories: measured at amortized cost, measured at fair value with changes recognized in other comprehensive income, and measured at fair value with changes recognized in profit or loss[91]. Employee Compensation and Benefits - The company has a defined contribution plan for post-employment benefits, primarily involving social insurance contributions, which are recognized as liabilities during the service period[143]. - The company reported a total of CNY 31,380,047.62 in wages, bonuses, and allowances for employees during the period[199]. Inventory and Asset Management - The ending balance of inventory is CNY 57,667,947.21, down from CNY 67,961,367.74 at the beginning of the period, representing a decrease of approximately 15.5%[169]. - The provision for inventory impairment at the end of the period is CNY 1,274,397.47, compared to CNY 1,771,824.96 at the beginning, indicating a reduction of about 28%[170].